Edition:
United States

Mauna Kea Technologies SAS (MKEA.PA)

MKEA.PA on Paris Stock Exchange

3.02EUR
12:35pm EDT
Change (% chg)

€0.03 (+1.00%)
Prev Close
€2.99
Open
€3.03
Day's High
€3.04
Day's Low
€2.96
Volume
174,131
Avg. Vol
179,510
52-wk High
€4.53
52-wk Low
€1.51

Latest Key Developments (Source: Significant Developments)

Mauna Kea Technologies FY net loss narrows to 9.7 million euros
Thursday, 23 Mar 2017 12:45pm EDT 

Mauna Kea Technologies SAS : FY net loss of 9.7 million euros ($10.46 million) versus loss of 12.6 million euros year ago . FY operating loss of 10.0 million euros versus loss of 12.7 million euros year ago . In 2017 plans to increase adoption of Cellvizio through a new consignment model in U.S., which represents a $2.8 billion recurring revenue opportunity for company`s core GI business .In 2017 plans to execute on commercial partnership strategy, including Cook Medical global partnership in urology, to efficiently expand company`s market opportunity.  Full Article

Mauna Kea reports highlighted superiority of endomicroscopy in the diagnosis of stomach cancer
Thursday, 2 Mar 2017 12:19pm EST 

Mauna Kea Technologies SAS : Reports comparison of imaging technologies highlights superiority of endomicroscopy in the diagnosis of stomach cancer in vivo . Superiority of endomicroscopy for the diagnosis of gastric cancer highlighted in a peer-reviewed publication comparing advanced imaging technologies .  Full Article

Mauna Kea secures a 7.0 million euros debt financing
Wednesday, 8 Feb 2017 11:45am EST 

Mauna Kea Technologies SAS :Mauna Kea Technologies secures a 7.0 million euros ($7.49 million) debt financing.  Full Article

Mauna Kea technologies appoints John Soto as chief operating officer
Thursday, 2 Feb 2017 11:45am EST 

Mauna Kea Technologies SAS : Mauna Kea technologies appoints John Soto as chief operating officer .Mr. Soto succeeds Pierre Forest who has resigned to pursue other interests.  Full Article

Mauna Kea Technologies obtains financing for Cellvizio from BPIFrance
Wednesday, 30 Nov 2016 12:36pm EST 

Mauna Kea Technologies SAS : Persee study demonstrates the applicability of cellvizio in digestive cancer surgery, and leads to new financing by BPIFrance . BPIFrance validates the financing of the next key step of the amount of 626,000 euros ($662,433.20) Further company coverage: [MKEA.PA] ($1 = 0.9450 euros) (Gdynia Newsroom) ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;)).  Full Article

Mauna Kea announces capital increase of about 4.4 mln euros
Wednesday, 13 Jul 2016 01:23am EDT 

Mauna Kea Technologies SA : Announced on Tuesday capital increase of about 4.4 million euros ($4.9 million) . Capitali increase proposes 2,980,131 outstanding share at a nominal value of 0.04 euro .Price of new shares is at 1.49 euros (14.49 pct discount compared with weighted average price per volume of the last three trading days).  Full Article

Mauna Kea Technologies Q2 sales rise to 2.5 million euros
Tuesday, 12 Jul 2016 12:16pm EDT 

Mauna Kea Technologies SAS : Q2 sales EUR 2.5 million ($2.77 million) versus EUR 2.2 million year ago .Says cash position was EUR 5.7 million on June 30.  Full Article

Mauna Kea Technologies gets new Cellvizio order for Rouen University Hospital
Thursday, 30 Jun 2016 12:15pm EDT 

Mauna Kea Technologies SAS :New Cellvizio order placed by UGAP for Rouen University Hospital.  Full Article

Mauna Kea Technologies receives FDA clearance for near-infrared surgical miniprobes
Wednesday, 25 May 2016 11:45am EDT 

Mauna Kea Technologies SAS :Mauna Kea Technologies receives U.S. FDA clearance for its near-infrared surgical miniprobes.  Full Article

Mauna Kea Technologies appoints Pierre Forest as Chief Operating Officer
Tuesday, 17 May 2016 11:57am EDT 

Mauna Kea Technologies SAS :Mauna Kea Technologies appoints Pierre Forest as Chief Operating Officer.  Full Article

More From Around the Web

BRIEF-Mauna Kea secures a 7.0 million euros debt financing

* Mauna Kea Technologies secures a 7.0 million euros ($7.49 million) debt financing Source text for Eikon: